AI is about to change healthcare. These 40 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.
To own National Vision, you need to believe its value-focused, brick and mortar eyecare model can still grow in a world of rising online competition and tight optometrist supply. The Russell index additions increase visibility, but do not materially change the near term tug of war between managed care driven growth and the key risk of ongoing e commerce and direct to consumer pressure on store traffic and pricing.
The most relevant recent development here is the company’s Q1 2026 earnings, which showed higher revenue and a return to profitability versus the prior year. That improvement underpins the current catalyst around expanding managed care volumes and premium assortments, and the new Russell growth index inclusion could draw in more institutions that are watching how sustainable these margin gains prove to be against rising online and labor headwinds.
Yet, while index inclusion is helpful, investors should be aware that the real test will be how National Vision handles growing online competition and...
Read the full narrative on National Vision Holdings (it's free!)
National Vision Holdings' narrative projects $2.3 billion revenue and $118.0 million earnings by 2029.
Uncover how National Vision Holdings' forecasts yield a $35.27 fair value, a 81% upside to its current price.
Some of the most optimistic analysts were already modeling revenue reaching about US$2.5 billion and earnings near US$113 million by 2029, assuming rapid modernization and digital gains, so this index news could either reinforce that bullish view or prompt you to reconsider how realistic those expectations really are.
Explore another fair value estimate on National Vision Holdings - why the stock might be worth as much as 52% more than the current price!
Disagree with existing narratives? Extraordinary investment returns rarely come from following the herd, so go with your instincts.
Right now could be the best entry point. These picks are fresh from our daily scans. Don't delay:
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com